Mario Filion
Gründer bei Alethia Biotherapeutics, Inc.
Aktive Positionen von Mario Filion
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Alethia Biotherapeutics, Inc.
 Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alethia Biotherapeutics, Inc. discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets. The firm focuses on bone loss in acute disorders, invasive carcinomas and on cancer-associated epithelial-to-mesenchymal transition. The company was founded in 2002 by Mario Filion and Yves Cornellier and is headquartered in Montreal, Canada. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2002 | - |
| Gründer | 20.07.2009 | - |
Karriereverlauf von Mario Filion
Ehemalige bekannte Positionen von Mario Filion
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| FORTALEZA ENERGY INC. | Corporate Officer/Principal | - | - |
| SignalGene, Inc. | Corporate Officer/Principal | - | - |
Ausbildung von Mario Filion
| University of Montréal | Doctorate Degree |
Statistik
International
| Kanada | 5 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sektoral
| Energy Minerals | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Fortaleza Energy, Inc.
 Fortaleza Energy, Inc. Oil & Gas ProductionEnergy Minerals Fortaleza Energy, Inc. is an oil and gas company, which engages in the exploration, development, and production of crude oil and natural gas. It also provides custom acid blending services for fracture stimulation and production optimization fluids through its wholly owned subsidiary, BlendForce Energy Services Inc. The company was founded on January 15, 2007 and is headquartered in Calgary, Canada. | Energy Minerals |
Alethia Biotherapeutics, Inc.
Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alethia Biotherapeutics, Inc. discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets. The firm focuses on bone loss in acute disorders, invasive carcinomas and on cancer-associated epithelial-to-mesenchymal transition. The company was founded in 2002 by Mario Filion and Yves Cornellier and is headquartered in Montreal, Canada. | Health Technology |
| SignalGene, Inc. |
- Börse
- Insiders
- Mario Filion
- Erfahrung
